Dyne Therapeutics, Inc. · NASDAQ:DYN
Kerr Douglas sold 1,556 Dyne Therapeutics, Inc. shares (Form 4)
Traded Aug 13, 2026 · Filed Aug 17, 2026
On Aug 13, 2026, Kerr Douglas (Chief Medical Officer) sold 1,556 Dyne Therapeutics, Inc. shares at US$26.28 for US$40,892 under a trading plan, leaving 167,599 shares. Filed Aug 17, 2026 (Form 4).
- Sold
- 1,556 shares
- Price
- US$26.28
- Value
- US$40,892
- Holding after
- 167,599 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 13, 2026 | Common Stock | Sale | 1,556 | US$26.28 | 167,599 | Direct |
Source
Related
- Dyne Therapeutics, Inc.
- Kerr Douglas
- Dyne Therapeutics, Inc. shareholders
- Form 4 · Kerr Douglas · Sep 8, 2026
- Form 4 · Kerr Douglas · Jun 17, 2026
- Form 4 · Kerr Douglas · May 14, 2026
- Form 4 · Posner Brian S · Oct 6, 2026
- Form 4 · Friedl-Naderer Johanna · Sep 8, 2026
- Form 4 · Cox John · Sep 8, 2026
- Form 4 · Rhodes Jason P · Aug 17, 2026
- Form 4 · Cox John · Aug 17, 2026